G
GenoFocus Inc
KOSDAQ:187420
GenoFocus Inc
KOSDAQ:187420
Price:
2 815
KRW
-2.93%
Market Cap:
₩82.2B
Balance Sheet
Balance Sheet Decomposition
GenoFocus Inc
GenoFocus Inc
Balance Sheet Decomposition is not available for
GenoFocus Inc
GenoFocus Inc
Balance Sheet
GenoFocus Inc
GenoFocus Inc
Currency: KRW
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
711
|
6 313
|
5 288
|
9 297
|
21 275
|
3 164
|
2 776
|
13 056
|
22 030
|
25 115
|
40 047
|
29 865
|
83 807
|
|
| Cash Equivalents |
711
|
6 313
|
5 288
|
9 297
|
21 275
|
3 164
|
2 776
|
13 056
|
22 030
|
25 115
|
40 047
|
29 865
|
83 807
|
|
| Short-Term Investments |
0
|
0
|
66
|
856
|
14 562
|
20 122
|
5 477
|
8 898
|
13 529
|
500
|
1 500
|
0
|
0
|
|
| Total Receivables |
300
|
660
|
2 375
|
706
|
2 046
|
3 912
|
5 011
|
5 610
|
3 420
|
5 871
|
8 168
|
7 430
|
7 641
|
|
| Accounts Receivables |
300
|
660
|
2 375
|
706
|
2 046
|
3 221
|
4 847
|
5 410
|
3 389
|
5 848
|
7 861
|
6 582
|
7 487
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
691
|
164
|
200
|
31
|
23
|
308
|
848
|
154
|
|
| Inventory |
157
|
272
|
314
|
435
|
581
|
2 073
|
2 073
|
2 727
|
4 307
|
4 877
|
5 542
|
5 490
|
5 867
|
|
| Other Current Assets |
54
|
119
|
334
|
435
|
327
|
889
|
1 665
|
775
|
1 054
|
949
|
173
|
268
|
140
|
|
| Total Current Assets |
1 222
|
7 365
|
8 376
|
11 729
|
38 790
|
30 160
|
17 003
|
31 066
|
44 339
|
37 313
|
55 431
|
43 054
|
97 455
|
|
| PP&E Net |
802
|
943
|
5 729
|
13 458
|
17 359
|
28 803
|
34 871
|
39 830
|
53 890
|
60 494
|
61 171
|
43 259
|
40 078
|
|
| PP&E Gross |
802
|
943
|
5 729
|
13 458
|
17 359
|
28 803
|
34 871
|
39 830
|
53 890
|
60 494
|
61 171
|
43 259
|
40 078
|
|
| Accumulated Depreciation |
611
|
685
|
765
|
696
|
1 035
|
12 602
|
13 885
|
14 600
|
12 187
|
15 540
|
19 553
|
24 405
|
27 582
|
|
| Intangible Assets |
177
|
656
|
1 789
|
3 189
|
4 463
|
6 176
|
6 498
|
5 734
|
2 756
|
2 847
|
2 892
|
1 790
|
1 539
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
514
|
514
|
514
|
514
|
514
|
514
|
514
|
514
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
734
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
30
|
6
|
610
|
595
|
2 088
|
7 931
|
8 388
|
8 547
|
7 458
|
7 073
|
2 994
|
746
|
|
| Other Long-Term Assets |
5
|
7
|
1 041
|
1 537
|
2 017
|
2 409
|
3 518
|
3 936
|
3 182
|
9 896
|
6 833
|
6 253
|
5 930
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
514
|
514
|
514
|
514
|
514
|
514
|
514
|
514
|
|
| Total Assets |
2 206
N/A
|
9 000
+308%
|
16 941
+88%
|
30 523
+80%
|
63 226
+107%
|
70 151
+11%
|
70 335
+0%
|
90 202
+28%
|
113 227
+26%
|
118 523
+5%
|
133 914
+13%
|
97 863
-27%
|
146 262
+49%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
120
|
18
|
117
|
218
|
46
|
308
|
1 794
|
2 562
|
724
|
1 045
|
887
|
933
|
1 222
|
|
| Accrued Liabilities |
65
|
45
|
161
|
118
|
340
|
145
|
191
|
311
|
404
|
433
|
693
|
843
|
1 150
|
|
| Short-Term Debt |
1 615
|
597
|
520
|
0
|
0
|
1 401
|
1 400
|
6 400
|
6 250
|
6 500
|
6 000
|
5 500
|
11 800
|
|
| Current Portion of Long-Term Debt |
17
|
67
|
2 493
|
0
|
0
|
0
|
0
|
62
|
21 423
|
25 461
|
65 343
|
49 239
|
25 547
|
|
| Other Current Liabilities |
215
|
133
|
200
|
281
|
196
|
383
|
1 000
|
1 264
|
12 090
|
18 544
|
20 931
|
3 902
|
51 145
|
|
| Total Current Liabilities |
2 032
|
859
|
3 491
|
617
|
581
|
2 237
|
4 385
|
10 599
|
40 891
|
51 984
|
93 854
|
60 417
|
90 864
|
|
| Long-Term Debt |
183
|
5 488
|
3 513
|
0
|
0
|
1 200
|
4 235
|
21 681
|
27 104
|
26 940
|
12 416
|
10 696
|
7 226
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
2 343
|
1 352
|
3 958
|
5 173
|
3 527
|
3 182
|
4 325
|
4 452
|
|
| Other Liabilities |
288
|
302
|
276
|
120
|
128
|
153
|
151
|
1 844
|
291
|
794
|
570
|
388
|
19 951
|
|
| Total Liabilities |
2 503
N/A
|
6 649
+166%
|
7 280
+9%
|
736
-90%
|
710
-4%
|
5 932
+735%
|
10 124
+71%
|
38 081
+276%
|
73 460
+93%
|
83 244
+13%
|
110 022
+32%
|
75 826
-31%
|
122 492
+62%
|
|
| Equity | ||||||||||||||
| Common Stock |
1 926
|
2 759
|
3 060
|
4 470
|
5 393
|
5 430
|
10 902
|
11 053
|
11 200
|
11 250
|
11 263
|
11 379
|
14 568
|
|
| Retained Earnings |
4 438
|
4 291
|
2 109
|
898
|
717
|
2 128
|
472
|
6 230
|
18 446
|
23 861
|
36 829
|
39 779
|
58 607
|
|
| Additional Paid In Capital |
2 216
|
3 883
|
8 699
|
26 192
|
56 416
|
56 805
|
49 971
|
52 115
|
52 880
|
52 698
|
47 766
|
50 252
|
69 196
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
40
|
781
|
709
|
171
|
1 359
|
154
|
1 919
|
|
| Other Equity |
1
|
0
|
12
|
23
|
10
|
144
|
149
|
4 036
|
5 157
|
4 637
|
334
|
338
|
532
|
|
| Total Equity |
297
N/A
|
2 351
N/A
|
9 661
+311%
|
29 787
+208%
|
62 516
+110%
|
64 219
+3%
|
60 211
-6%
|
52 121
-13%
|
39 767
-24%
|
35 279
-11%
|
23 892
-32%
|
22 037
-8%
|
23 770
+8%
|
|
| Total Liabilities & Equity |
2 206
N/A
|
9 000
+308%
|
16 941
+88%
|
30 523
+80%
|
63 226
+107%
|
70 151
+11%
|
70 335
+0%
|
90 202
+28%
|
113 227
+26%
|
118 523
+5%
|
133 914
+13%
|
97 863
-27%
|
146 262
+49%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
8
|
11
|
11
|
18
|
20
|
20
|
22
|
22
|
22
|
22
|
23
|
23
|
29
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
